Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure

Circulation

Volumn 99, Issue 16, 1999, Pages 2113-2117

  Katz, Stuart D ^a,b   Khan, Tehreen ^a   Zeballos, Guillermo A ^a   Mathew, Leena ^a   Potharlanka, Prathibha ^a   Knecht, Mathias ^a   Whelan, James ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Endothelium; Isotopes; Metabolism; Nitric oxide; Vessels

Indexed keywords

ARGININE; NITRATE; NITRIC OXIDE; UREA;

ADULT; AGED; AMINO ACID SYNTHESIS; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0033609027     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.16.2113     Document Type: Article

References (35)

1. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
2. Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res. 1994;31:131-143.
3. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, Sutton MGSJ, Selwyn AP, Alexander RW, Ganz P. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990;81:772-779.
4. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589-1596.
5. Katz SD, Krum H, Khan T, Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol. 1996;28:585-590.
6. Adachi H, Nguyen PH, Belardinelli R, Hunter D, Jung T, Wassermann K. Nitric oxide production during exercise in chronic heart failure. Am Heart J. 1997;133:196-202.
7. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, Macdonald PS. Increased nitric oxide production in heart failure. Lancet. 1994;344:373-374.
8. Kubo SH, Rector TS, Raij L, Bank AJ, Kraemer MD, Tadros P, Beardslee M, Garr MD. Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. Am J Cardiol. 1994;74:1133-1136.
9. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JGF. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet. 1994;344:371-373.
10. Leaf CD, Wishnok JS, Hurley JP, Rosenblad WD, Fox JG, Tannenbaum SR. Nitrate biosynthesis in rats, ferrets and humans: precursor studies with L-arginine. Carcinogenesis. 1990;11:855-858.
11. Castillo L, Chapman TE, Yu Y-M, Ajami A, Burke JF, Young VR. Dietary arginine uptake by the splanchnic region in adult humans. Am J Phvsiol. 1993;265:E532-E539.
12. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet. 1997;349: 837-842.
13. Hibbs JBJ, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, Samlowski WE. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest. 1992;89:867-877.
14. Prabhakar SS, Zeballos GA, Montoya-Zavala M, Leornard C. Urea inhibits inducible nitric oxide synthase in macrophage cell line. Am J Physiol. 1997;273:C1882-C1888.
15. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and 15N-nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
16. Greenfield ADM, Whitney RJ, Mowbray JF. Methods for the investigation of peripheral blood flow. Br Med Bull. 1963;19:101-109.
17. Wang J, Seyedi N, Xiao-Bin X, Wolin MS, Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol. 1994;266:H670-H680.
18. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu XB, Kobari Y, Pritchard K Jr, Sessa WC, Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 1996;78:58-64.
19. Jungersten L, Edlund A, Petersson A-S, Wennmalm Å. Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. Clin Physiol. 1996;16:369-379.
20. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
21. G-monomethyl-L-arginine in human end-stage renal failure patients on regular haemodialysis Exp Physiol. 1996;81:475-481.
22. Arnold AMO, Ribeiro JP, Colucci WS. Muscle blood flow during forearm exercise in patients with severe heart failure. Circulation. 1990; 82:465-472.
23. Sinoway L, Minotti J, Musch T, Goldner D, Davis D, Leaman D, Zelis R. Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1987;60:107-111.
24. Mancini DM, Davis L, Wexler JP, Chadwick B, LeJemtel TH. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure. J Am Coll Cardiol. 1987;10:845-850.
25. Rowell LB. Control of Blood Flow to Dynamically Active Muscles: Human Cardiovascular Control. New York, NY: Oxford University Press; 1993:255-301.
26. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
27. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, LeJemtel TH. Pathophysiologic correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation. 1994;90:1609-1614.
28. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed lett ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201-1206.
29. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S. Nitric oxide synthase activities in human myocardium [see comments]. Lancet. 1993;341:84-85.
30. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure [see comments]. Circulation. 1996; 93:1087-1094.
31. Brenner BM, Dworkin LD, Ichikawa I. Glomerular Ultrafiltration. In: Brenner BM, Rector FC Jr, eds. The Kidney. 3rd ed. Philadelphia, Pa: WB Saunders; 1986:124-144.
32. Hanssen H, Brunini TMC, Conway M, Banning AP, Roberts NB, Mann GE, Ellory JC, Mendes Ribeiro AC. Increased L-arginine transport in human erythrocytes in chronic heart failure. Clin Sci. 1997;94:43-48.
33. Beaumier L, Castillo L, Yu YM, Ajami AM, Young VR. Arginine: new and exciting developments for an "old" amino acid. Biomed Environ Sci. 1996;9:296-315.
34. Chin-Dusting JP, Kaye DM, Lefkovits J, Wong J, Bergin P, Jennings GL. Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol. 1996;27:1207-1213.
35. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) Study [see comments] [published erratum appears in Circulation. 1996;94:1490]. Circulation. 1996;94:258-265.